Weight loss and wasting in patients infected with human immunodeficiency virus

scientific article published in April 2003

Weight loss and wasting in patients infected with human immunodeficiency virus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/367561
P8608Fatcat IDrelease_zv72si2aozactffev4dzmkx5s4
P698PubMed publication ID12652374
P5875ResearchGate publication ID10843175

P2093author name stringSteven Grinspoon
Kathleen Mulligan
Department of Health and Human Services Working Group on the Prevention and Treatment of Wasting and Weight Loss
P433issueSuppl 2
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
P304page(s)S69-78
P577publication date2003-04-01
P1433published inClinical Infectious DiseasesQ5133764
P1476titleWeight loss and wasting in patients infected with human immunodeficiency virus
P478volume36

Reverse relations

cites work (P2860)
Q40437873Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study
Q36234618Anthropometric Improvement among HIV Infected Pre-School Children Following Initiation of First Line Anti-Retroviral Therapy: Implications for Follow Up
Q37111462Association of the veterans aging cohort study index with exercise capacity in HIV-infected adults.
Q37685937Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries
Q38095828Bone health and human immunodeficiency virus infection
Q34629748Central activation, muscle performance, and physical function in men infected with human immunodeficiency virus
Q45409913Chronic alcohol accentuates nutritional, metabolic, and immune alterations during asymptomatic simian immunodeficiency virus infection
Q35226613Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting
Q34574213Chronic binge alcohol administration accentuates expression of pro-fibrotic and inflammatory genes in the skeletal muscle of simian immunodeficiency virus-infected macaques
Q26765257Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS
Q58190298Cost-effectiveness of clinical interventions for AIDS wasting
Q33412387Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study
Q35884663Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial
Q37600614Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection
Q30496599Domestic water carrying and its implications for health: a review and mixed methods pilot study in Limpopo Province, South Africa
Q42252177Effects of combined exercise training on immunological, physical and biochemical parameters in individuals with HIV/AIDS.
Q46957628Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting
Q33554616Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial
Q36705832Free radical-mediated skeletal muscle dysfunction in inflammatory conditions
Q33629133HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection
Q35520112Health & nutritional status of HIV infected children.
Q42163337Herpes virus entry mediator signaling in the brain is imperative in acute inflammation-induced anorexia and body weight loss
Q51157712High prevalence of food insecurity among HIV-infected individuals receiving HAART in a resource-rich setting.
Q37642702High risk of obesity and weight gain for HIV-infected uninsured minorities
Q40073553Human immunodeficiency virus-associated heart failure in sub-Saharan Africa: evolution in the epidemiology, pathophysiology, and clinical manifestations in the antiretroviral era.
Q48333429Hypothalamic POMC expression is required for peripheral insulin action on hepatic gluconeogenesis through regulating STAT3 in sepsis rats
Q37475891Hypothalamic activation is essential for endotoxemia-induced acute muscle wasting
Q24672467IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS
Q36462022Long-term impact of HIV wasting on physical function
Q36417157Mammalian cell-derived somatropin : a review of its use in the management of HIV-associated wasting
Q38056813Metabonomic analysis of HIV-infected biofluids
Q33744644NF-kappaB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness- and leptin-induced anorexia
Q34734134Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapy
Q33553170Nutrition issues in chronic drug users living with HIV infection
Q35126803Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.
Q40446793Physical fitness characteristics of active duty US Air Force members with HIV infection
Q40520851Placental leptin mRNA expression and serum leptin levels in pre-eclampsia associated with HIV infection
Q34661639Predictors of change in CD4 lymphocyte count and weight among HIV infected patients on anti-retroviral treatment in Ethiopia: a retrospective longitudinal study
Q36278045Recombinant human growth hormone therapy in HIV-associated wasting and visceral adiposity
Q34550863Reducing plasma HIV RNA improves muscle amino acid metabolism
Q40818605Role of intestinal dysfunction in the nutritional compromise seen in human immunodeficiency virus-infected adults in rural India
Q93270645Sarcopenia in people living with the Human Immunodeficiency Virus: a systematic review and meta-analysis
Q35578704Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings
Q47244577Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors
Q36487277The association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study
Q43063695The benefit of supplementary feeding for wasted Malawian adults initiating ART.
Q61807828The physical sequelae of perinatally acquired HIV in adolescents: a research proposal
Q56970729The relationship between lower limb muscle strength and lower extremity function in HIV disease
Q36027433Topical testosterone treatment for chronic allograft failure in liver transplant recipients with recurrent hepatitis C virus
Q36835326Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients
Q46774522Whole body leucine flux in HIV-infected patients treated with or without protease inhibitors
Q39068277Women's input into household decisions and their nutritional status in three resource-constrained settings
Q82421976[Muscular complications of human immunodeficiency virus (HIV) infection in the era of effective anti-retroviral therapy]

Search more.